Clyde Baily
Researcher
Also affiliated: Royal Victoria Eye and Ear Hospital (2017); Winthrop Rockefeller Foundation (2023)
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Clyde Baily's research focuses on evaluating outcomes for patients with multiple myeloma undergoing hematopoietic stem cell transplantation. His work utilizes retrospective study designs to assess risk stratification tools, such as the R2-ISS score, in predicting patient outcomes. Baily has published research examining the application of these tools in the context of autologous stem cell transplants at the University of Arkansas for Medical Sciences (UAMS). His scholarship metrics include an h-index of 2, with 3 total publications and 14 total citations. Key collaborators at UAMS include Guido Tricot, David E. Mery, John D. Shaughnessy, and Maurizio Zangari, with whom he has co-authored publications.
Metrics
- h-index: 2
- Publications: 3
- Citations: 15
Selected Publications
-
Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS (2023)
Collaboration Network
Top Collaborators
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
- Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Similar Researchers
Based on overlapping research topics